Leo Pavliv - May 31, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
SVP and Chief Development Off.
Signature
Leo Pavliv by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
May 31, 2022
Transactions value $
-$70,015
Form type
4
Date filed
7/1/2022, 03:13 PM
Previous filing
Apr 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Other -$70K -33.5K -20.54% $2.09 130K May 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Disposed to Issuer $0 -5K -100% $0.00* 0 Mar 17, 2021 Common Stock 5K $3.22 Direct F1
transaction CPIX Options (right to buy) Disposed to Issuer $0 -5K -100% $0.00* 0 Mar 16, 2022 Common Stock 5K $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Leo Pavliv is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement.